Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.

Shou Tung Chen; Syh Yi Lin; Kun Tu Yeh; Shou Jen Kuo; Wen Ling Chan; Yen Ping Chu; Jan Gowth Chang

Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.

Shou Tung Chen, Syh Yi Lin, Kun Tu Yeh, Shou Jen Kuo, Wen Ling Chan, Yen Ping Chu, Jan Gowth Chang

Research output: Contribution to journal › Article › peer-review

Abstract

Caveolin-1, an integral membrane protein of caveolae found in many cell types, has been suggested as a candidate tumor suppressor. However, the mechanism underlying caveolin-1 decreased expression is not fully understood. The purpose of this study is to investigate the role of aberrant promoter methylation in the regulation of caveolin-1 gene in breast cancer correlated with clinical findings. We used methylation specific PCR, direct sequencing and immunohistochemistry stain methods to explore the role of caveolin-1 gene in the development of breast cancer. We demonstrated that 14 of 55 cases (25.5%) and 4 of 55 cases (7.3%) had methylated CpG-island on caveolin-1 promoter in cancerous and non-cancerous cells, respectively. The frequency of aberrant promoter methylation of breast cancer tissues was significant higher than non-cancerous tissues (p

Original language	English
Pages (from-to)	577-582
Number of pages	6
Journal	International Journal of Molecular Medicine
Volume	14
Issue number	4
Publication status	Published - Oct 2004
Externally published	Yes

ASJC Scopus subject areas

Genetics

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Fingerprint Dive into the research topics of 'Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.'. Together they form a unique fingerprint.

Cite this

@article{46c651514f3144f98eb1775751d06480,

title = "Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.",

abstract = "Caveolin-1, an integral membrane protein of caveolae found in many cell types, has been suggested as a candidate tumor suppressor. However, the mechanism underlying caveolin-1 decreased expression is not fully understood. The purpose of this study is to investigate the role of aberrant promoter methylation in the regulation of caveolin-1 gene in breast cancer correlated with clinical findings. We used methylation specific PCR, direct sequencing and immunohistochemistry stain methods to explore the role of caveolin-1 gene in the development of breast cancer. We demonstrated that 14 of 55 cases (25.5%) and 4 of 55 cases (7.3%) had methylated CpG-island on caveolin-1 promoter in cancerous and non-cancerous cells, respectively. The frequency of aberrant promoter methylation of breast cancer tissues was significant higher than non-cancerous tissues (p",

author = "Chen, {Shou Tung} and Lin, {Syh Yi} and Yeh, {Kun Tu} and Kuo, {Shou Jen} and Chan, {Wen Ling} and Chu, {Yen Ping} and Chang, {Jan Gowth}",

year = "2004",

month = oct,

language = "English",

volume = "14",

pages = "577--582",

journal = "International Journal of Molecular Medicine",

issn = "1107-3756",

publisher = "Spandidos Publications",

number = "4",

}

TY - JOUR

T1 - Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.

AU - Chen, Shou Tung

AU - Lin, Syh Yi

AU - Yeh, Kun Tu

AU - Kuo, Shou Jen

AU - Chan, Wen Ling

AU - Chu, Yen Ping

AU - Chang, Jan Gowth

PY - 2004/10

Y1 - 2004/10

N2 - Caveolin-1, an integral membrane protein of caveolae found in many cell types, has been suggested as a candidate tumor suppressor. However, the mechanism underlying caveolin-1 decreased expression is not fully understood. The purpose of this study is to investigate the role of aberrant promoter methylation in the regulation of caveolin-1 gene in breast cancer correlated with clinical findings. We used methylation specific PCR, direct sequencing and immunohistochemistry stain methods to explore the role of caveolin-1 gene in the development of breast cancer. We demonstrated that 14 of 55 cases (25.5%) and 4 of 55 cases (7.3%) had methylated CpG-island on caveolin-1 promoter in cancerous and non-cancerous cells, respectively. The frequency of aberrant promoter methylation of breast cancer tissues was significant higher than non-cancerous tissues (p

AB - Caveolin-1, an integral membrane protein of caveolae found in many cell types, has been suggested as a candidate tumor suppressor. However, the mechanism underlying caveolin-1 decreased expression is not fully understood. The purpose of this study is to investigate the role of aberrant promoter methylation in the regulation of caveolin-1 gene in breast cancer correlated with clinical findings. We used methylation specific PCR, direct sequencing and immunohistochemistry stain methods to explore the role of caveolin-1 gene in the development of breast cancer. We demonstrated that 14 of 55 cases (25.5%) and 4 of 55 cases (7.3%) had methylated CpG-island on caveolin-1 promoter in cancerous and non-cancerous cells, respectively. The frequency of aberrant promoter methylation of breast cancer tissues was significant higher than non-cancerous tissues (p

UR - http://www.scopus.com/inward/record.url?scp=16644374354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644374354&partnerID=8YFLogxK

M3 - Article

C2 - 15375584

AN - SCOPUS:16644374354

VL - 14

SP - 577

EP - 582

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 4

ER -

Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this